Related Experiment Video
Updated: Jun 6, 2025
09:15
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
14.6K
Ezetimibe: Integrating Established Use with New Evidence - A Comprehensive Review
Elena Olmastroni1,2, Stefano Scotti1,2, Federica Galimberti2
1Epidemiology and Preventive Pharmacology Service (SEFAP), Department of Pharmacological and Biomolecular Sciences (DiSFeB), University of Milan, Milan, Italy.
Current Atherosclerosis Reports
|November 25, 2024
Summary
Ezetimibe is a valuable lipid-lowering drug, effective when added to statins or used with bempedoic acid for statin-intolerant patients. It offers improved cardiovascular risk reduction with good tolerability.
Area of Science:
- Cardiovascular Medicine
- Pharmacology
- Lipid Metabolism
Background:
- Ezetimibe is a cholesterol absorption inhibitor.
- It is commonly used as an adjunct to statin therapy or for patients with statin intolerance.
Purpose of the Study:
- To review the latest evidence on the efficacy and safety of ezetimibe.
- To highlight ezetimibe's evolving role in cardiovascular risk reduction.
Main Methods:
- Literature review of recent studies on ezetimibe.
- Analysis of clinical trial data and real-world evidence.
Main Results:
- Ezetimibe, when added to statins, effectively lowers LDL cholesterol in high-risk patients.
- Combination therapy with ezetimibe and bempedoic acid significantly reduces LDL cholesterol in statin-intolerant individuals.
- Ezetimibe demonstrates a favorable safety profile with fewer side effects compared to statins.
Conclusions:
- Ezetimibe is a key therapeutic option for optimizing lipid management.
- Its efficacy, safety, and combination potential enhance cardiovascular risk reduction strategies.
- Fixed-dose combinations improve treatment adherence and efficacy.
Related Concept Videos
01:20Antiepileptic Drugs: Potassium Channel Activators
146
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
146
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
536
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
536
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
479
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
479
01:25Drug Regulation
1.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.3K
01:22Myocarditis IV: Nursing Management
2
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
2
01:16Bioequivalence: Overview
926
Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
926